Saturday , February 29 2020
Home / Lance Roberts Real Investment Advice / Market Vaccine For Virus Is More Fed’s “NotQE”

Market Vaccine For Virus Is More Fed’s “NotQE”

Summary:
Market Vaccine For Virus Is More Fed Trust The Process MacroView: The Next Minsky Moment Is Inevitable Financial Planning Corner: 5-Things You Need To Know About HSA’s Sector & Market Analysis 401k Plan Manager Follow Us On: Twitter, Facebook, Linked-In, Sound Cloud, Seeking Alpha Catch Up On What You Missed Last Week Market Vaccine For Virus Is More Fed  Last week, I asked the question of whether the “correction was over?” To wit: “On a very short-term basis, there is a potential for a reflexive bounce. If your ‘investment duration,’ or rather your ‘investment holding period’ is very short, there may be a ‘trading’ opportunity for you.” Well, that bounce came hard and fast during the first half of the week, as the S&P 500 rebounded off the 50-dma to set new highs on Thursday.  The

Topics:
Lance Roberts considers the following as important: , , , , , , , , , , ,

This could be interesting, too:

Lance Roberts writes #WhatYouMissed On RIA: Week Of 02-24-20

Lance Roberts writes Robertson: One Is The Loneliest Number

Barry Ritholtz writes No, It Is Not a Bubble (Yet)

Lance Roberts writes Quick Take: Recession Risks Tick Up

Market Vaccine For Virus Is More Fed’s “NotQE”


  • Market Vaccine For Virus Is More Fed
  • Trust The Process
  • MacroView: The Next Minsky Moment Is Inevitable
  • Financial Planning Corner: 5-Things You Need To Know About HSA’s
  • Sector & Market Analysis
  • 401k Plan Manager

Follow Us On: Sound Cloud, Seeking Alpha


Market Vaccine For Virus Is More Fed’s “NotQE”


Catch Up On What You Missed Last Week

Market Vaccine For Virus Is More Fed’s “NotQE”


Market Vaccine For Virus Is More Fed 

Last week, I asked the question of whether the “correction was over?” To wit:

“On a very short-term basis, there is a potential for a reflexive bounce. If your ‘investment duration,’ or rather your ‘investment holding period’ is very short, there may be a ‘trading’ opportunity for you.”

Well, that bounce came hard and fast during the first half of the week, as the S&P 500 rebounded off the 50-dma to set new highs on Thursday. 

Market Vaccine For Virus Is More Fed’s “NotQE”

The Good News

As noted, the market bounced firmly off the 50-dma and rallied back to new highs on Thursday. While Friday saw a bit of retracement, which isn’t surprising given the torrid move early in the week, the “virus correction” was recovered. Importantly, the “buy signal,” in the lower panel, was close to registering a “sell signal.” The sharp early-week rally kept that signal from triggering, which would have confirmed the “sell signal” in the top panel. Historically, when both “sell signals” are triggered, deeper corrections have tended to follow.

The Not-So-Good News

Previously, we discussed that we had taken profits out of portfolios as we were expecting between a 3-5% correction to allow for a better entry point to add equity exposure. While the “virus correction” did encompass a correction of 3%, it was too shallow to reverse the rather extreme extension of the market. The rally this past week has reversed the corrective process, and returned the markets to 3-standard deviations above the 200-dma. Furthermore, all daily, weekly, and monthly conditions have returned to more extreme overbought levels as well.

Market Vaccine For Virus Is More Fed’s “NotQE”

Of course, the reason for the rally was more liquidity from the Federal Reserve. 

Market Vaccine For Virus Is More Fed’s “NotQE”

While the economic impact from the virus is likely to be substantial, as discussed previously, traders looked past economic realities. They focused instead on more liquidity being pumped into the markets by both the Fed, and the PBOC (Peoples Bank of China).

“The PBOC decided that instead of unwinding the large liquidity provision, they would double-down on it… and that they did in size. The last four weeks have seen China supply over CNY2 trillion (net!) into its financial system – something we have never seen anything like before…” – Zerohedge

Market Vaccine For Virus Is More Fed’s “NotQE”

But, as I stated, it wasn’t just the PBOC, but also the Federal Reserve dumping tremendous amounts of liquidity into the markets which only had one place to go….equities.

Market Vaccine For Virus Is More Fed’s “NotQE”

While the Fed continues to deny current liquidity interventions are indeed “QE,” they have been clearly concerned about the potential of global instability impacting the U.S. In their most recent report to Congress, the “coronavirus” made its appearance as the latest threat to the global economic instability. 

Do NOT dismiss that last sentence lightly. 

Since last October, the Fed has been injecting the financial system with massive quantities of liquidity to fix “short-term funding needs.” Each time they have tried to slow the rates of funding, the market has declined, so they extended the facility. Initially, the facility was for October tax payments. Then it was extended for the “year-end” turn. Then it was extended for April “tax payments.” The “coronavirus” will be the next reason to extend the program into June.

Just in case you missed our previous report on this issue, the importance is that this type of funding has not occurred to such a magnitude outside of a financial crisis.

Market Vaccine For Virus Is More Fed’s “NotQE”

The question you should be asking is: “exactly what is going on?”

Dollar Rally

Currently, the flood of liquidity has been pulling foreign capital back into U.S. Dollars. While the U.S. dollar had previously started to breakdown heading into year-end, which gave a boost to commodities and oil. Unfortunately, that breakdown has been reversed.

We did this analysis for our RIAPRO Subscribers (Risk-Free Trial For 30-Days) this past week, which warned them of the potential for a continued dollar rally. The importance of this rally is that a stronger U.S. Dollar is not friendly to commodities, international, and emerging market exposure.

Market Vaccine For Virus Is More Fed’s “NotQE”

Market Vaccine For Virus Is More Fed’s “NotQE”

While there has been a good bit of excitement over the last couple of weeks of improving economic data points, it will likely be short-lived. Given these data points are both “sentiment surveys” and “lagging” in nature, what they captured was the uptick in commodities seen at the end of 2019 as the dollar weakened on “trade deal” hopes.

Market Vaccine For Virus Is More Fed’s “NotQE”

What has yet to be captured is the subsequent reversion in the major, economically sensitive, components. While the markets have rallied on news of more liquidity, the impact from the “coronavirus” has only yet started to be felt economically. Even if the virus was cured today, the economic impact will continue to be felt over the rest of this year. 

Importantly, the impact on China will be substantially greater, which will undermine any potential positive to the U.S. from the “trade deal.” That impact will result not only in the form of weaker economic growth in China, but globally as well due to the interlinked supply chains. This is going to manifest itself in weaker earnings and corporate profits, which will continue to make elevated asset prices harder to justify. 

As shown in the long-term chart below, despite the short-term correction, which is barely noticeable, the market remains extremely extended, overbought, and pushing into the top of its long-term trading range. 

Market Vaccine For Virus Is More Fed’s “NotQE”

Furthermore, the put/call ratio, which warned of the previous correction is once again pushing extreme levels rarely seen from a historical perspective.

Market Vaccine For Virus Is More Fed’s “NotQE”

The rally this past week serves as a stern reminder that market participants are trained to respond to “Pavlov’s Bell.” 

For the time being, investors have gotten away with overpaying for value, ignoring risk, and chasing yield. Eventually, the party ends, and it always ends in the most brutal of fashions.

This is why it’s important to have a process and adhere to it.

Market Vaccine For Virus Is More Fed’s “NotQE”

Trust The Process

We have had quite a few emails from readers over the past week asking why we were “buying” into our RIAPRO portfolios this past week(You can register for a 30-day RISK-FREE trial if you want to view our current portfolios.)

The short answer is: 

“Because that is what our process required us to do.” 

To understand the process, we have to go back. 

A few weeks ago, Shawn Langlois at MarketWatch picked up our article discussing why we were selling positions in our portfolio. To wit:

“Specifically, Roberts raised cash by selling off shares of Apple, Microsoft, United Healthcare, Johnson & Johnson, and Micron, and scaling back overweight holdings in various ETF sector plays, such as the Technology Select Sector SPDR, and the Health Care Select Sector.

While at the time, it seemed like a wrong move, a couple of weeks later, the market sold off. The benefit was the extra cash, and reduced exposure, help limit the downside draw to about 1/3rd of the market decline. 

Then, last week, things changed:

“With bond yields plummeting this past week, our bond exposures have gotten extremely stretched. The sell-off in the market, combined with the ‘risk off’ rotation to bonds, sets the market up for a reflexive bounce. The duration and magnitude of that bounce will be critical as to our next steps in positioning.” 

Chart updated through Friday

Market Vaccine For Virus Is More Fed’s “NotQE”

As noted, the market had gotten oversold on a short-term basis, which brought the risk/reward measures back into better alignment. This is where our process required we add equity exposure back into portfolios. 

  • In the ETF Model, we added Financials (XLF) and increased our stake in HealthCare (XLV) with both of those sectors having gotten oversold and bouncing off their respective 50-dma’s.
  • In the EQUITY Model, we added JP Morgan (JPM) and Pfizer (PFE) while increasing our stakes in Abbvie (ABBV), United Healthcare (UNH), and Alerian MLP (AMLP). 

Importantly, this rebalancing of risk did not dramatically increase our equity exposure. This is because, as noted above, the longer-term technical outlook remains “cautious.”

Yes, we realize we are very late-cycle, we also know that with the Fed, and global Central Banks, still intervening, we must give deference to the “bullish bias.” At the moment, the bullish bias remains, and functioned as we predicted last week.

“The ‘bullish bias’ is not dead as of yet, and investors will be quick to try and ‘write off’ the impact of the ‘virus.’ After a decade of ‘macro-events’ not stopping the bullish charge, the belief the market is ‘bulletproof’ has become so deeply ingrained into investor mentality it won’t be dislodged until it is far too late to matter.”

We have no certainty about when, or what will trigger the next bear market. 

What we do know is that such an event will likely be far more brutal than most realize due to years of excess risk-taking, leverage, and demographics. 

However, this is what our process is designed to handle:

  • The portfolio is managed for risk by adjusting the level of equity exposure relative to market dynamics, return outlooks, and technical deviations from long-term means.
  • The allocation is managed for risk by balancing positions for relative performance to our benchmark.
  • The positions are managed for risk by:
    • Employing trailing stop-losses
    • Regularly rebalancing positions back to target weights (taking profits)
    • Cutting laggards which aren’t performing as expected
    • Monitoring relative performance and participation

Importantly, notice that everything the process covers is the management against the “risk” of loss. 

If we manage against the risk of capital loss, we can safely participate with markets as they rise. When something eventually does goes wrong, the process will systematically close out positions, protecting our investment capital, until that process is complete. Then the process reverses to rebuild exposure when risk/reward dynamics are greatly improved. 

As long as the process is followed, risk can be controlled. Where the majority of investors go wrong, is by not having a process.

“Hoping” markets will continue higher indefinitely, is not a process.

As we concluded last week:

“We won’t know for sure until after the fact. This is why we manage risk in the short-term. Managing risk allows us to navigate the ‘twists and turns’ of the market without careening off the cliff.”


Market Vaccine For Virus Is More Fed’s “NotQE”


Market Vaccine For Virus Is More Fed’s “NotQE”

If you need help or have questions, we are always glad to help. Just email me.

See You Next Week

By Lance Roberts, CIO


  • REGISTER NOW:  RIGHT-LANE RETIREMENT WORKSHOP
  • When: February 29th 9-11am  (Social Security, Medicare, Income planning, Investing & More)
  • Where: Courtyard Houston Katy Mills, 25402 Katy Mills Parkway, Katy, TX, 77494

Market Vaccine For Virus Is More Fed’s “NotQE”

You’ll be hearing more about more specific strategies to diversify soon, but don’t hesitate to give me any suggestions or questions.

by Danny Ratliff, CFP®


Data Analysis Of The Market & Sectors For Traders


MISSING THE REST OF THE NEWSLETTER?

This is what our RIAPRO.NET subscribers are reading right now!

  • Sector & Market Analysis
  • Technical Gauges
  • Sector Rotation Analysis
  • Portfolio Positioning
  • Sector & Market Recommendations
  • Client Portfolio Updates
  • Live 401k Plan Manager

Market Vaccine For Virus Is More Fed’s “NotQE”

A Conservative Strategy For Long-Term Investors


The 401k plan allocation plan below follows the K.I.S.S. principle. By keeping the allocation simplified, it allows for better control of the allocation, and closer tracking to the benchmark objective over time. (If you want to make it more complicated, you can, however, statistics show simply adding more funds does not increase performance to any significant degree.)

Market Vaccine For Virus Is More Fed’s “NotQE” Market Vaccine For Virus Is More Fed’s “NotQE”

If you need help after reading the alert; do not hesitate to contact me.

Click Here For The “LIVE” Version Of The 401k Plan Manager

See below for an example of a comparative model.


Model performance is based on a two-asset model of stocks and bonds relative to the weighting changes made each week in the newsletter. This is strictly for informational and educational purposes only and should not be relied upon for any reason. Past performance is not a guarantee of future results. Use at your own risk and peril.  

Market Vaccine For Virus Is More Fed’s “NotQE”

401k Plan Manager Live Model

As an RIA PRO subscriber (You get your first 30-days free) you have access to our live 401k p

 The code will give you access to the entire site during the 401k-BETA testing process, so not only will you get to help us work out the bugs on the 401k plan manager, you can submit your comments about the rest of the site as well.

We are building models specific to company plans. So, if you would like to see your company plan included specifically, send me the following:

  • Name of the company
  • Plan Sponsor
  • A print out of your plan choices. (Fund Symbol and Fund Name)

If you would like to offer our service to your employees at a deeply discounted corporate rate, please contact me.

Market Vaccine For Virus Is More Fed’s “NotQE”

Lance Roberts
Lance Roberts has sharpened that lens with 30 years in the investing world from private banking and investment management to private and venture capital. Lance Roberts’ perspective and common sense analysis is sought after by media outlets such as Fox 26 News in Houston, CNBC, CNN and Fox Business News along with numerous publications including the Wall Street Journal, USA Today, Reuters and the Washington Post. Roberts is the Editor of the X-Factor report and publishes the blog Daily X-change.

Leave a Reply

Your email address will not be published. Required fields are marked *